Oral Presentation

Total Publications

Oral Presentation

2024 · Oral Presentation · Oral Presentation · Hepatology

Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.

2024 · Oral Presentation · Oral Presentation · Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

2023 · Oral Presentation · Care · Dermatology

Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.

2023 · Oral Presentation · Care · Methods/Pharmacoepi

Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.

2023 · Oral Presentation · Oral Presentation · Hepatology

Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.

2023 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening.

2023 · Oral Presentation · Care · Dermatology

Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.

2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.

2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.

2021 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019.

2020 · Oral Presentation · Oral Presentation · Hepatology

Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus.

2020 · Oral Presentation · Oral Presentation · Gastroenterology

Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.

2020 · Oral Presentation · Approval / Commercialization · Hepatology

Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH.

2019 · Oral Presentation · Oral Presentation · Hepatology

Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort.

2019 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines.

2018 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi

Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States.

2017 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi